[CG] Endometrial hyperplasia, management


exp date isn't null, but text field is


Please report any inaccuracies or issues with this guideline using our online form

Endometrial cancer is the most common gynaecological malignancy in the Western world and endometrial hyperplasia is its precursor. The most common presentation of endometrial hyperplasia is abnormal uterine bleeding (this includes HMB, IMB, PMB and bleeding on HRT)


Use the button below to access this resource item.

Access this resource

Last reviewed: 18 September 2017

Next review: 31 August 2022

Author(s): Dr M Hair

Approved By: Dr R Jamieson, Clinical Director